BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 854866)

  • 1. The effect of Donalgin on locomotor disease.
    Abrányi I; Papp I
    Ther Hung; 1977; 25(1):20-3. PubMed ID: 854866
    [No Abstract]   [Full Text] [Related]  

  • 2. Examinations with Donalgin in locomotor diseases treated at the out-patient department.
    Kovács E
    Ther Hung; 1977; 25(2):75-8. PubMed ID: 302503
    [No Abstract]   [Full Text] [Related]  

  • 3. [Controlled clinical study on the use of morniflumate in the treatment of inflammatory-degenerative diseases of the locomotor system].
    Raffaetà G; Saponati G; Terzuoli A
    G Clin Med; 1987 Oct; 68(10):507-13. PubMed ID: 3428515
    [No Abstract]   [Full Text] [Related]  

  • 4. Clinical effectivity of Donalgin--niflumic acid--in locomotor diseases.
    Krakovits G; Tallián A; Képes P
    Ther Hung; 1981; 29(2):77-85. PubMed ID: 6765143
    [No Abstract]   [Full Text] [Related]  

  • 5. New means in the treatment of locomotor disorders of aged patients.
    Porkoláb E
    Ther Hung; 1978; 26(4):190-2. PubMed ID: 751278
    [No Abstract]   [Full Text] [Related]  

  • 6. [Effect of niflumic acid on chronic rheumatoid arthritis].
    Shichikawa K; Onoda T
    Ryumachi; 1976 May; 16(2):199-211. PubMed ID: 785616
    [No Abstract]   [Full Text] [Related]  

  • 7. Potentiation of Donalgin in the treatment of postinjection and postinfusion phlebitis.
    Horváth I; Illés T
    Ther Hung; 1980; 28(4):171-5. PubMed ID: 7209850
    [No Abstract]   [Full Text] [Related]  

  • 8. [Clinical evaluation of the preparation Donalgin in the treatment of rheumatoid arthritis and ankylosing spondylitis].
    Sadkiewicz S; Barwik-Schramm A; Grzywa M; Letkiewicz C; Piotrowska E; Procel Z; Reszkowska H; Wippel A; Woźniak M; Zmudzińska I
    Reumatologia; 1982; 20(1-2):75-80. PubMed ID: 6761815
    [No Abstract]   [Full Text] [Related]  

  • 9. [Comparative trial by double-blind method of a niflumic acid derivative and oxyphenbutazone in pediatric O. R. L].
    Traissac L; Roche JC
    Rev Laryngol Otol Rhinol (Bord); 1979; 100(1-2):151-61. PubMed ID: 379941
    [No Abstract]   [Full Text] [Related]  

  • 10. [Niflumic acid combined with gastroprotective agents in rheumatic pathology].
    Serni U; Frosecchi M
    Reumatismo; 1974; 26(2):109-28. PubMed ID: 4282512
    [No Abstract]   [Full Text] [Related]  

  • 11. Clinical examination of the synergistic effect of niflumic acid and tolperisone in genicular arthritis.
    Dömötör E
    Ther Hung; 1979; 27(3):129-33. PubMed ID: 531773
    [No Abstract]   [Full Text] [Related]  

  • 12. Experiences with the combined use of Mydocalm + Donalgin in the treatment of patients suffering from lumboischialgia.
    Kumin M; Saál M; Ambrózy G
    Ther Hung; 1984; 32(1):26-8. PubMed ID: 6242725
    [No Abstract]   [Full Text] [Related]  

  • 13. Niflumic acid in the management of rheumatoid and osteoarthritis.
    Tilve GH; Lengade JK; Bavadekar AV; Nair KG
    J Postgrad Med; 1976 Jul; 22(3):124-9. PubMed ID: 1032826
    [No Abstract]   [Full Text] [Related]  

  • 14. [Clinical study of the beta-morpholinoethylester of niflumic acid in children's dentistry].
    Benoit P; Michelet FX; Benoit JP
    Rev Odontostomatol Midi Fr; 1975; (4):249-61. PubMed ID: 1236592
    [No Abstract]   [Full Text] [Related]  

  • 15. [Contribution of an anti-inflammatory agent in pedodontics].
    Justin J; Blocquel H; Baudin M
    Lille Med; 1980; 25(7):390-7. PubMed ID: 6448940
    [No Abstract]   [Full Text] [Related]  

  • 16. [Niflumic acid in the treatment of rheumatic disease].
    Lejeune E; Queneau P; Falconnet M; Woerhle R
    Lyon Med; 1970 Mar; 223(11):635-40. PubMed ID: 5309784
    [No Abstract]   [Full Text] [Related]  

  • 17. A double-blind cross-over study of niflumic acid and indomethacin in rheumatoid arthritis.
    Gulati PD; Lamba S; Rizvi SN; Vaishnava H
    J Assoc Physicians India; 1975 Dec; 23(12):897-901. PubMed ID: 773919
    [No Abstract]   [Full Text] [Related]  

  • 18. [The beta-morpholino ethyl ester of niflumic acid in the treatment of orchi-epididymitis].
    Mazeman E; Biserte J
    Lille Med; 1980 Nov; 25(9):541-4. PubMed ID: 7453494
    [No Abstract]   [Full Text] [Related]  

  • 19. [Fluoride osteosis after 11 years of uninterrupted treatment with niflumic acid].
    Bregeon C; Bernat M; Renier JC; Rebel A; Basile M
    Nouv Presse Med; 1980 May; 9(20):1446-7. PubMed ID: 7383866
    [No Abstract]   [Full Text] [Related]  

  • 20. [Niflumic acid].
    Danysz A
    Reumatologia; 1975; 13(3):227-32. PubMed ID: 1101331
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.